Evidence map›Paper›PMID 36700407›Full record

ArticleHaematologica2023

COVID-19 thromboembolism is reduced in ambulatory, but not hospitalized patients, following COVID-19 vaccination.

Hannah Stevens, Sergio Ruiz-Carmona, Karlheinz Peter, James McFadyen

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hannah StevensDepartment of Haematology, Alfred Hospital, Melbourne, Victoria, Australia 3004; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia; Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria.
Sergio Ruiz-CarmonaCambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne.
Karlheinz PeterAtherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia 3004; Department of Cardiology, Alfred Hospital, Melbourne, Australia 3004; Baker Department of Cardiometabolic Health, The University of Melbourne, Victoria.
James McFadyenDepartment of Haematology, Alfred Hospital, Melbourne, Victoria, Australia 3004; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia; Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia 3004; Baker Department of Cardiometabolic Health, The University of Melbourne, Victoria. james.mcfadyen@monash.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19ThromboembolismVenous ThromboembolismCOVID-19 VaccinesHumansSARS-CoV-2VaccinationCOVID-19 Vaccines

Identifiers

PMID36700407
PMCPMC10483365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.